In addition to their well known role in hemostasis and thrombosis, platelets and endothelial cells participate in inflammation, and react with components of the immune system. Moreover, these cells express receptors for the early complement component C1q, which may function in innate immunity by mediating the phagocytosis of invading pathogens. Preliminary data suggest that gC1qR/p33, originally described as a binding site for the globular domain of C1q, recognizes both Staphylococcus aureus protein A (SPA) and fibrinogen. Thus, we hypothesize that gC1qR/p33 participates in both direct and indirect staphylococcal interactions with platelets and endothelial cells. Since S. aureus is a major etiologic agent of endovascular infections in humans, particularly infective endocarditis, understanding the molecular mechanisms involved in infection is of considerable importance. In vitro studies are proposed using human platelets, cultured human endothelial cells, and a CHO cell line expressing cell membrane gC1qR/p33 to characterize gC1qR/p33 mediated S. aureus adhesion to cell surfaces. SPA+ and SPA- isogenic strains of S. aureus, and isogenic S. aureus strains differing in their ability to adhere to and clump fibrinogen (ClfA+, ClfA-) will be tested to elucidate the involvement of SPA and fibrinogen in this process. Purified native and recombinant gC1qR/p33 and monoclonal and polyclonal anti gC1qR antibodies are available for competing with or blocking cell surface gC1qR/p33, respectively.
Specific aims are proposed 1) to characterize gC1qR/p33 -SPA binding, 2) to identify gC1qR/p33 as a platelet and endothelial cell binding site for S. aureus, 3) to examine the effect of circulating IgG and C1q on SPA-gC1qR/p33 binding, 4) to assess the role of gC1qR/p33 in S. aureus induced platelet aggregation and endothelial cell infection, and 5) to evaluate the ability of gC1qR/p33 to modulate S. aureus interactions with fibrinogen/fibrin in the extracellular matrix or on cell surfaces. Since S. aureus interactions with platelets and endothelial cells are complex and multimodal, in vivo studies are proposed using a well characterized rabbit endocarditis model to assess the role of gC1qR/p33 in S. aureus adhesion to sterile vegetations, infective lesion progression, and metastasis. Results from these studies will define a novel mechanism for S. aureus interactions at sites of endovascular damage, and may identify novel targets for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL067211-03
Application #
6686338
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Hasan, Ahmed AK
Project Start
2001-12-01
Project End
2005-11-30
Budget Start
2003-12-01
Budget End
2004-11-30
Support Year
3
Fiscal Year
2004
Total Cost
$296,625
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Pathology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Sethi, Shneh; Herrmann, Mathias; Roller, Jonas et al. (2011) Blockade of gC1qR/p33, a receptor for C1q, inhibits adherence of Staphylococcus aureus to the microvascular endothelium. Microvasc Res 82:66-72
Peerschke, Ellinor I; Yin, Wei; Ghebrehiwet, Berhane (2010) Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol 47:2170-5
Peerschke, Ellinor I B; Andemariam, Biree; Yin, Wei et al. (2010) Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura. Br J Haematol 148:638-45
Sansonno, Domenico; Tucci, Felicia Anna; Ghebrehiwet, Berhane et al. (2009) Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage. J Immunol 183:6013-20
Peerschke, E I B; Yin, W; Alpert, D R et al. (2009) Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies. Lupus 18:530-8
Yin, Wei; Ghebrehiwet, Berhane; Peerschke, Ellinor I B (2008) Expression of complement components and inhibitors on platelet microparticles. Platelets 19:225-33
Peerschke, Ellinor I B; Yin, Wei; Ghebrehiwet, Berhane (2008) Platelet mediated complement activation. Adv Exp Med Biol 632:81-91
Alpert, D; Mandl, L A; Erkan, D et al. (2008) Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann Rheum Dis 67:395-401
Yin, Wei; Ghebrehiwet, Berhane; Weksler, Babette et al. (2008) Regulated complement deposition on the surface of human endothelial cells: effect of tobacco smoke and shear stress. Thromb Res 122:221-8
Peerschke, Ellinor I B; Ghebrehiwet, Berhane (2007) The contribution of gC1qR/p33 in infection and inflammation. Immunobiology 212:333-42

Showing the most recent 10 out of 19 publications